Practical Geriatrics ›› 2022, Vol. 36 ›› Issue (12): 1251-1254.doi: 10.3969/j.issn.1003-9198.2022.12.016

Previous Articles     Next Articles

Median effective concentration and 95% effective concentration of remifentanil inhibiting pain response in elderly patients undergoing percutaneous kyphoplasty

RUAN Shan, CHEN Xia, YANG Wen, ZHANG Peng, GUI Bo, QU Lei-qiu   

  1. RUAN Shan, CHEN Xia, YANG Wen, GUI Bo, QU Lei-qiu. Department of Anesthesiology; ZHANG Peng. Department of Orthopedics, Jiangsu Province Official Hospital, Nanjing 210024, China
  • Received:2022-04-13 Online:2022-12-20 Published:2022-11-30

Abstract: Objective To explore the median effective concentration (EC50) and 95% effective concentration (EC95) of remifentanil inhibiting balloon dilation-induced pain response in the elderly patients undergoing percutaneous kyphoplasty (PKP). Methods The patients scheduled for selective PKP under monitored anesthesia care (MAC) were sequentially enrolled in this trial. Target-controlled infusion (TCI) of remifentanil was performed from 5 min before surgery to time-point of bone cement implantation. The plasma concentration of remifentanil was set at 1.44 ng/mL in the first patient, and the ratio of adjacent target concentrations was 1.2. When the patients were treated with balloon dilatation,the score of Numerical Rating Scale(NRS)>3 was regarded as positive reaction. When a positive reaction occurred, the next patient will be treated with an increased concentration gradient. And if a negative reaction occurred, the next patient will be treated with a decreased concentration gradient. The trial was finished until 6 intersections from positive reaction to negative one. EC50 and EC95 of remifentanil effectively inhibiting pain response induced by vertebral balloon dilatation in the elderly patients were calculated by Probit regression analysis method. Results A total of 20 patients were enrolled, with ASA grade Ⅰ-Ⅲ. TCI of remifentanil significantly decreased the intraoperative NRS in the elderly patients scheduled for PKP. By Probit regression analysis method, EC50 and EC95 of remifentanil inhibiting the pain response induced by balloon dilation in the elderly patients undergoing percutaneous kyphoplasty was 0.950 ng/mL (95%CI: 0.768-1.103 ng/mL) and 1.179 ng/mL (95%CI: 1.049-4.595 ng/mL), respectively. Conclusions TCI of remifentanil can effectively inhibit the pain response induced by balloon dilation in the elderly patients undergoing PKP. EC50 and EC95 of remifentanil is 0.950 ng/mL and 1.179 ng/mL, respectively.

Key words: remifentanil, percutaneous kyphoplasty, target controlled infusion, median effective concentration, 95% effective concentration

CLC Number: